The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to https://sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures.
Trademarks and/or registered trademarks mentioned herein, including associated logos, are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries.
© 2020 DH Tech. Dev. Pte. Ltd.
Danaher Corporation (NYSE: DHR) today announced that it has signed a definitive agreement with MDS Inc. (TSX: MDS; NYSE: MDZ) to acquire the Analytical Technologies division of MDS, which includes a 50% ownership position in Applied Biosystems/MDS Sciex joint venture (“SCIEX”), a mass spectrometry business, and a 100% ownership position in the former Molecular Devices Corporation, a bioresearch and analytical instrumentation company.
Applied Biosystems Inc. (NYSE:ABI) and its joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (NYSE:MDZ) (TSX:MDS), today announced the introduction of two of the most advanced mass spectrometry systems ever built -- the SCIEX Triple QuadTM 5500 and the SCIEX QTRAP® 5500 Systems - - both of which will provide researchers with complete workflow solutions that are unmatched in terms of functionality, speed and performance.
These next-generation systems are the result of a new mass spectrometry platform being introduced today by Applied Biosystems/MDS Analytical Technologies. Designed with input from hundreds of customers, this new platform includes state-of-the-art electronics, new ion optics architecture, a number of newly designed components and a 44% smaller footprint than previous systems. These advancements were made to: increase sensitivity and speed in qualitative analysis; drive the highest quantitative accuracy to the lowest levels of detection for mass spectrometry systems; and, significantly accelerate the speed of analysis when compared to other instruments.
To advance a wide variety of life science applications, scientists have been calling for mass spectrometry-based systems to deliver higher performance and greater reproducibility. They are also seeking more accuracy and better integration of quantitative and qualitative capabilities in order to increase the confidence in the results of their experiments. "Mass spectrometry continues to evolve with more scientists using this technique for a growing number of new applications," said Laura Lauman, president for Applied Biosystems' proteomics and small molecule division. "These innovative systems incorporate intuitive software and comprehensive support to take performance to a new level. Applied Biosystems and MDS Analytical Technologies remain keenly focused on providing innovative solutions. These nextgeneration systems, which we believe are the most advanced mass spectrometers ever built, further demonstrate our continued commitment to our customers around the world."
The SCIEX Triple Quad 5500 System and the SCIEX QTRAP 5500 System are powerful and versatile next-generation mass spectrometers that enable complete workflow solutions, comprised of systems, software and applications. These next-generation systems were designed to expand the utility and effectiveness of mass spectrometry. "We continue to innovate, setting new standards of performance for mass spectrometry systems," said Andy Boorn, president of MDS Analytical Technologies. "The delivery of these next-generation systems is part of our continued focus on pushing the boundaries of innovation, and it is an example of the capabilities of our newly reorganized research and development teams. Applied Biosystems and MDS Analytical Technologies remain committed to the success of our mass spectrometry customers."
About the SCIEX Triple QuadTM 5500 System
The SCIEX Triple Quad 5500 System introduces the next-generation in triple quadrupole mass spectrometry. This new triple quadrupole system surpasses the performance specifications of the industry-leading API 5000TM System, delivering the most accurate quantitative results at the industry's fastest scan speeds to identify the greatest number of target analytes at the lowest concentrations in complex samples. This new level of speed and sensitivity enables a greater amount of data to be acquired from an experiment, which leads to greater quantitative accuracy and lower limits of detection, compared to competitive triple quadrupole instruments. This is critical in high-throughput applications that require samples to be screened for extremely large numbers of target analytes, such as contaminant analyses in food or drinking water.
This system also delivers a new standard of performance for triple quadrupoles by combining industry-leading sensitivity and the new pulse-counting detector known as AcQuRateTM, which effectively detects ions to increase quantitative accuracy and precision. This enables a 5x increase in sensitivity, compared to competitive triple quadrupole instruments. The combination of best-in-class sensitivity and unsurpassed speed allows scientists to analyze a comprehensive range of compounds in a shorter period of time than it currently takes with existing triple quadrupole systems. These capabilities are enabled by new components called eQTM Electronics and the Qurved LINAC® Collision Cell, which are both designed to generate shorter pause and dwell times, which enable high duty cycles for superior performance. The end result is faster analysis than what was previously possible, enabling scientists to measure a greater number of compounds in a single pass.
About the SCIEX QTRAP® 5500 System
The SCIEX QTRAP 5500 System is a unique, next-generation mass spectrometer that integrates triple quadrupole capabilities with a new innovation in ion trap technology called Linear AcceleratorTM Trap for quantitative and qualitative analysis. This system integrates all of the features of the SCIEX Triple Quad 5500 System, combining them with the new Linear Accelerator Trap technology. This combination results in the only system on the market that seamlessly integrates industry-leading sensitivity and high performance for both quantitative and qualitative analysis.
The SCIEX QTRAP 5500 System uniquely enables scientists to both identify and confirm results in a single analysis, without sacrificing performance. In qualitative mode, the system can provide up to 100 times more sensitivity, depending on the type of experiment. It also delivers ultra-fast scanning and high capacity, provided by the new eQ Electronics as well as the new Linear Accelerator Trap, which is designed to set a new standard in the linear ion trap-based qualitative mode. This combination of sensitivity, scanning speed and capacity enables a greater number of compounds, proteins and contaminants to be analyzed than competitive systems that are intended to do similar analyses.
The QTRAP 5500 System also uniquely supports multiple experiments on the same instrument. This is made possible by a proprietary innovation called TripleTrapTM Scanning that allows scientists to move from sensitive, specific, triple quadrupole scan modes to highly sensitive fullscan ion trap mode in less than one millisecond. This facilitates workflow-driven data acquisition that cannot be done on any other mass spectrometry system, as this work typically requires systems for each of these functions.
Enabling a Variety of Workflows
The advancements in these next-generation mass spectrometers are expected to enable a variety of workflows, designed to advance specific objectives in several important areas of scientific interest. These applications include: driving greater efficiency in drug discovery; advancing research for better understanding of diseases; and, helping to support efforts to improve human health and safety. For example:
Innovation and Leadership in Mass Spectrometry
The new SCIEX 5500 systems enable powerful solutions when combined with other industryleading technologies from Applied Biosystems/MDS Analytical Technologies, such as: LightSight® Software for metabolite identification; Cliquid® Software for food, environmental, forensic and clinical research markets; MRMPilotTM and MultiQuantTM software for targeted quantitative proteomics, as well as mTRAQTM Reagents. The Applied Biosystems/MDS Analytical Technologies joint venture has a more than 20-year history of innovation and is a market leader in mass spectrometry with more than 12,000 systems installed in laboratories worldwide.
To view initial reaction to the new SCIEX 5500 systems from scientists in various industries, please visit: http://info.appliedbiosystems.com/5500customerfeedback.
News Conference Webcast Today
To watch a live Web news conference of executives from Applied Biosystems and MDS Analytical Technologies at 10 a.m. (EDT) today, please go to: http://info.appliedbiosystems.com/5500WebCast. This Webcast will include remarks and Q&A with Mark Stevenson, president and chief operating officer of Applied Biosystems, Laura Lauman, president for Applied Biosystems' proteomics and small molecule division, and Andy Boorn,president of MDS Analytical Technologies.
An archived version of the video will be available within a few hours after the live Webcast at: info.appliedbiosystems.com/5500. For information on how to participate in the media Q&A, please contact Anthony Petrucci in Applied Biosystems' Public Relations department at email@example.com.
Investor Conference Call Today
Applied Biosystems Inc. will host a conference call with investors today at 11:00 a.m. (ET). During the call, Laura Lauman, division president, and other leaders in the company's mass spectrometry business will answer questions from investors, securities analysts and other interested parties. To access the call, dial 617-213-8894 and enter passcode 91444728 at any time from 10:45 a.m. until the end of the call. This conference call will also be webcast. Interested parties who wish to listen to the webcast should visit the "Investors & Media" section of www.appliedbiosystems.com. A digital recording will be available approximately two hours after the completion of the conference call on October 9 until October 23, 2008 and may be accessed by dialing 617-801-6888 and entering passcode 77063530.
About Applied Biosystems Inc.
Applied Biosystems Inc. (formerly known as Applera Corporation) is a global leader in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. Driven by its employees' belief in the power of science to improve the human condition, the company commercializes innovative technology solutions for DNA, RNA, protein and small molecule analysis. Customers across the disciplines of academic and clinical research, pharmaceutical research and manufacturing, forensic DNA analysis, and agricultural biotechnology use the company's tools and services to accelerate scientific discovery, improve processes related to drug discovery and development, detect potentially pathogenic microorganisms, and identify individuals based on DNA sources. Applied Biosystems has a comprehensive service and field applications support team for a global installed base of high-performance genetic and protein analysis solutions. Applied Biosystems is headquartered in Norwalk, CT. On June 12, 2008, Applera Corporation and Invitrogen Corporation (NASDAQ:IVGN) announced that their Boards of Directors had approved a definitive merger agreement under which Invitrogen will acquire all of the outstanding shares of Applied Biosystems stock. The merger is subject to customary closing conditions and is targeted to close in the fall of 2008. Further information regarding the merger has been provided in a joint proxy statement/prospectus mailed to stockholders of the company and Invitrogen. Investors and security holders are urged to read this document because it contains important information. All information in this news release is as of the date of the release, and Applied Biosystems does not undertake any duty to update this information unless required by law.
About MDS Analytical Technologies
MDS Analytical Technologies, a business unit of MDS Inc., is focused on the research, design, manufacture and marketing of state-of-the-art tools for mass-spectrometry, drug discovery and bioresearch. MDS Analytical Technologies products are designed to help accelerate the complex process of discovering and developing new drug compounds, and are sold to research scientists around the world. The mass-spectrometer product lines are also sold globally through joint ventures with two of the world's leading analytical instrumentation and life sciences companies, Applied Biosystems Inc and PerkinElmer Inc.
For Research Use Only. Not for use in diagnostic procedures.
Applied Biosystems Forward Looking Statements Certain statements in this press release are forward-looking. These may be identified by the use of forward-looking words or phrases such as "should," "expect," and "planned," among others. These forward-looking statements are based on Applied Biosystems' current expectations. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. In order to comply with the terms of the safe harbor, Applied Biosystems notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. These factors include but are not limited to: (1) rapidly changing technology and dependence on the development and customer acceptance of new products; (2) sales dependent on customers' spending policies; and (3) other factors that might be described from time to time in Applied Biosystems' filings with the Securities and Exchange Commission.
©Copyright 2008. Applied Biosystems and MDS Inc. Joint Owners. All rights reserved. Applied Biosystems, AB (design) and mTRAQ are registered trademarks of Applied Biosystems or its subsidiaries in the US and/or certain other countries. MDS is a registered trademark of MDS Inc. in the U.S. and/or certain other countries. SCIEX Triple Quad, AcQuRate, API 5000, eQ, Linear Accelerator, MRMPilot, MultiQuant and TripleTrap are trademarks and Cliquid, LINAC, LightSight and QTRAP are registered trademarks of Applied Biosystems/MDS Analytical Technologies
A new password has been sent to your email.
You have added a user.
Unfortunately the serial number you provided shows as inactive in our database. Would you like to submit the case anyway?
This serial number could not be found. Would you like to submit the case anyway?
Your password has been updated.
Your account is now created.
A verification link has been sent to your email.
A new password has been sent to your email.
Your insturment has been removed.
Your privacy settings are now updated.
Unfortunately the serial number you provided shows as inactive in our database. Please open a support case here if you require more assistance.
Software has already been registered to another instrument. Please check your AID and try again.
If you want to change the License Key to another instrument, please submit a new case.
Software has already been registered to the instrument selected.
Please check your instrument's software by going to the Instruments page and selecting the instrument in your "My Instruments" section. Here you will see a Software tab where you can view your instrument's software information.
You can also go to the Registered Software page to view software associated with your instrument(s).
If you are not finding what you are looking for, please submit a new case.